ArticleJournal for immunotherapy of cancer2020

Efficient elimination of primary B-ALL cells in vitro and in vivo using a novel 4-1BB-based CAR targeting a membrane-distal CD22 epitope.

Talia Velasco-Hernandez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.